Nazia chaudhary

Employment

• Advanced Centre for Treatment, Research and Education in Cancer DST Inspire faculty
  2015 - Present

Education

Education history is unavailable.

Projects & Funding

Projects & funding information is unavailable.

Publications (38)

• Data from Patient-Derived Organoids and Xenografts Uncover Therapeutic Vulnerabilities in Colorectal Signet Ring Cell Carcinomas
  2025 DOI: 10.1158/1078-0432.c.7747632
  +Save
• Low-GPX4 drives a sustained drug-tolerant persister state in TNBC by a targetable adaptive FSP1 upregulation
  Redox Biology 2025 DOI: 10.1016/J.REDOX.2025.103864
  +Save
• Inhibiting de novo lipogenesis identifies a therapeutic vulnerability in therapy-resistant colorectal cancer
  Redox Biology 2025 DOI: 10.1016/J.REDOX.2024.103458
  +Save
• Exploring the role of daidzin as a phytotherapeutic agent in imatinib-resistant CML through in-silico and in-vitro modulation of BCL2 and ABL1
  Chemical Papers-chemicke Zvesti 2025 DOI: 10.1007/S11696-025-04359-Z
  +Save
• EGFR-to-Src family tyrosine kinase switching in proliferating-DTP TNBC cells creates a hyperphosphorylation-dependent vulnerability to EGFR TKI
  Cancer Cell International 2025 DOI: 10.1186/S12935-025-03691-4
  +Save
• Development and characterization of pegylated Fe3O4-CAPE magnetic nanoparticles for targeted therapy and hyperthermia treatment of colorectal cancer
  Scientific Reports 2025 DOI: 10.1038/S41598-025-11927-6
  +Save
• DKC1 promotes colorectal cancer progression and therapy resistance by dysregulating sphingolipid biosynthesis
  Cancer Research 2025 DOI: 10.1158/1538-7445.AM2025-6805
  +Save
• Supplementary Table S8 from Patient-Derived Organoids and Xenografts Uncover Therapeutic Vulnerabilities in Colorectal Signet Ring Cell Carcinomas
  2025 DOI: 10.1158/1078-0432.28704009
  +Save
• Supplementary Table S7 from Patient-Derived Organoids and Xenografts Uncover Therapeutic Vulnerabilities in Colorectal Signet Ring Cell Carcinomas
  2025 DOI: 10.1158/1078-0432.28704015
  +Save
• Supplementary Table S6 from Patient-Derived Organoids and Xenografts Uncover Therapeutic Vulnerabilities in Colorectal Signet Ring Cell Carcinomas
  2025 DOI: 10.1158/1078-0432.28704018
  +Save